Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abeona Therapeutics (ABEO) Shares Outstanding (2016 - 2025)

Abeona Therapeutics has reported Shares Outstanding over the past 15 years, most recently at $55.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $55.0 million for Q4 2025, up 20.59% from a year ago — trailing twelve months through Dec 2025 was $55.0 million (up 20.59% YoY), and the annual figure for FY2025 was $55.0 million, up 20.59%.
  • Shares Outstanding for Q4 2025 was $55.0 million at Abeona Therapeutics, up from $52.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ABEO hit a ceiling of $55.0 million in Q4 2025 and a floor of $4.0 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $23.1 million (2023), compared with a mean of $25.6 million.
  • Biggest five-year swings in Shares Outstanding: plummeted 95.26% in 2021 and later surged 265.87% in 2023.
  • Abeona Therapeutics' Shares Outstanding stood at $5.9 million in 2021, then skyrocketed by 200.94% to $17.7 million in 2022, then skyrocketed by 49.69% to $26.5 million in 2023, then soared by 72.09% to $45.6 million in 2024, then increased by 20.59% to $55.0 million in 2025.
  • The last three reported values for Shares Outstanding were $55.0 million (Q4 2025), $52.4 million (Q3 2025), and $51.2 million (Q2 2025) per Business Quant data.